Our new R01 grant is funded by the NIH/NCI

This 5-year grant will address the mechanisms of resistance to chemotherapy in highly aggressive breast cancers using cutting-edge methodologies, including testing our recently developed LOX inhibitors. NEW positions are available for highly motivated postdocs and graduate students.

Leave a Reply

Your email address will not be published.